Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Microbiome-Driven Modulation of Immune Reconstitution and Vaccine Responsiveness in Multiple Myeloma Patients following Stem Cell Transplantation

Objetivo

The gut microbiome is a key regulator of human immunity, shaping responses to infection, vaccination, and cancer. Population-level differences in microbiome composition and function have been linked to variable vaccine efficacy, yet the mechanisms remain poorly understood. During defined physiological or clinical windows, the equilibrium between host and microbiome becomes particularly vulnerable, and transient perturbations can durably imprint on immune function and disease risk. Hematopoietic stem cell transplantation (SCT), a cornerstone therapy for hematologic cancers such as multiple myeloma (MM), represents one such scenario, marked by profound microbiome disruption, immune reconstitution, and the need for re-vaccination. MM patients often mount poor vaccine responses and experience infection-related morbidity. This setting uniquely enables the investigation of host-microbiome-vaccine interactions in a controlled yet physiologically authentic context, offering insights unattainable in healthy adults.
Through MicroMM, I will define how microbiome perturbations during SCT shape immune recovery, vaccine responsiveness, and clinical outcome in MM patients. Leveraging a longitudinal cohort, I will integrate functional microbiome analyses, high-resolution immune profiling, and serial vaccine monitoring, focusing on vaccines with known variability post-SCT. Advanced computational modeling will identify microbiome signatures predictive of vaccine efficacy and immune resilience. To establish causality, mechanistic studies in gnotobiotic mice colonized with patient-derived microbiomes will dissect microbial contributions to immune imprinting, vaccine performance, and tumor control. By bridging clinical observation with mechanistic experimentation, MicroMM will uncover fundamental principles of microbiome-driven immune modulation and define actionable biomarkers to improve vaccine responsiveness and immune resilience in at-risk populations.

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-ERC - HORIZON ERC Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) ERC-2026-STG

Ver todos los proyectos financiados en el marco de esta convocatoria

Institución de acogida

TECHNISCHE UNIVERSITAET MUENCHEN
Aportación neta de la UEn
€ 1 060 873,00
Dirección
Arcisstrasse 21
80333 Muenchen
Alemania
Región
Bayern Oberbayern München, Kreisfreie Stadt
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 1 060 873,00

Beneficiarios (2)